Three grassroots foundations started by the families of boys with Duchenne muscular dystrophy (DMD) have come together to award…
Articles by Margarida Azevedo, MSc
Parent Project Muscular Dystrophy (PPMD), a nonprofit group dedicated to ending Duchenne muscular dystrophy (DMD), has named the…
Eighteen-year-old Brandon Martz will travel from Michigan to Washington, D.C., to raise awareness for muscular dystrophy (MD) and see…
Catabasis Pharmaceuticals is facing challenges in its efforts to develop Edasalonexent (CAT-1004) — an oral drug that targets NF-kB, a…
Solid Biosciences of Cambridge, Mass., has completed the initial closing of a $50 million Series C round of financing to…
The nonprofit CureDuchenne organization has changed its website to better reflect its mission of improving the lives of people with…
Hundreds seeking a cure for Duchenne muscular dystrophy will join April 8 at the University of Texas (UT) Golf Club…
Summit Therapeutics has confirmed plans for an extension stage of a Phase…
Data from RECENSUS, a medical chart review of boys with X-linked myotubular myopathy (XLMTM), demonstrates the significant medical burden for…
Akashi Therapeutics has received an all-clear signal from the U.S. Food and Drug Administration to resume developing a Duchenne muscular…